|
BLOC1S1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.618370E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.132200E-02 |
| Normal-vs-Stage2 |
8.838900E-03 |
| Normal-vs-Stage3 |
4.045600E-02 |
| Normal-vs-Stage4 |
3.432400E-01 |
| Stage1-vs-Stage2 |
1.125210E-01 |
| Stage1-vs-Stage3 |
6.139800E-01 |
| Stage1-vs-Stage4 |
3.186800E-01 |
| Stage2-vs-Stage3 |
2.248400E-01 |
| Stage2-vs-Stage4 |
4.284300E-02 |
| Stage3-vs-Stage4 |
2.035400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.226200E-02 |
| Normal-vs-AfricanAmerican |
3.386800E-01 |
| Normal-vs-Asian |
6.801600E-02 |
| Caucasian-vs-AfricanAmerican |
7.334800E-01 |
| Caucasian-vs-Asian |
6.156800E-01 |
| AfricanAmerican-vs-Asian |
5.197600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.174100E-02 |
| Normal-vs-Female |
2.415800E-02 |
| Male-vs-Female |
7.050600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.520200E-02 |
| Normal-vs-Age(41-60Yrs) |
2.832400E-02 |
| Normal-vs-Age(61-80Yrs) |
7.293600E-02 |
| Normal-vs-Age(81-100Yrs) |
3.970400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.515400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.998800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.235600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.536000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.820800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.135800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.812400E-01 |
| Classical-VS-Follicular |
2.03529999999175E-05 |
| Classical-VS-Other |
3.112000E-01 |
| Classical-VS-Normal |
1.825020E-01 |
| Tall-VS-Follicular |
2.633600E-04 |
| Tall-VS-Other |
3.012400E-01 |
| Tall-VS-Normal |
9.883800E-01 |
| Follicular-VS-Other |
7.057400E-01 |
| Follicular-VS-Normal |
2.21809999999545E-05 |
| Other-VS-Normal |
2.992600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.281800E-03 |
| Normal-vs-N1 |
5.459700E-02 |
| N0-vs-N1 |
8.967200E-01 |
|
|
